Literature DB >> 6903083

Does a renal vasodilator system mediate racial differences in essential hypertension?

S E Warren, D T O'Connor.   

Abstract

Clinical and epidemiologic data support the contention that black people have a higher incidence and severity of essential hypertension than white people, a phenomenon which is likely due to genetic factors. Physiologic profiles in such patients reveal a striking prevalence of low renin, volume-expanded hypertension, with an exaggerated propensity to sodium retention. A deficiency in the natriuretic, vasodilatory renal kallikrein-kinin system may explain these phenomena and may be of practical importance in the selection of therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6903083     DOI: 10.1016/0002-9343(80)90015-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

2.  Variation in hypertension prevalence in elderly blacks in the United States: the effect of mortality trends.

Authors:  E L Kelly; W Neser; R Francis
Journal:  J Natl Med Assoc       Date:  1989-02       Impact factor: 1.798

3.  Propranolol versus labetalol: interesting differences in efficacy.

Authors:  W Flamenbaum
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

4.  Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.

Authors:  B E Pannier; V G Garabedian; O Madonna; M Fouchard; B Darne; M E Safar
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 5.  The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.

Authors:  J R M'Buyamba-Kabangu; M Tambwe
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 6.  Kidney disease in African Americans: genetic considerations.

Authors:  Deborah A Price; Errol D Crook
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.